A detailed history of Xtx Topco LTD transactions in Cytosorbents Corp stock. As of the latest transaction made, Xtx Topco LTD holds 30,113 shares of CTSO stock, worth $25,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,113
Previous 22,792 32.12%
Holding current value
$25,897
Previous $20,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025

BUY
$0.89 - $1.3 $6,515 - $9,517
7,321 Added 32.12%
30,113 $30,000
Q4 2024

Feb 13, 2025

BUY
$0.74 - $1.35 $5,801 - $10,584
7,840 Added 52.43%
22,792 $20,000
Q3 2024

Nov 14, 2024

BUY
$0.7 - $1.55 $10,466 - $23,175
14,952 New
14,952 $22,000

Others Institutions Holding CTSO

About Cytosorbents Corp


  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $37.5M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.